同仁堂国药(08138)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08138 同仁堂国药

午间休市 05-28 16:08:38

17.500

+0.120

+0.69%

最高17.840	最低16.940	成交量183.57万
今开17.500	昨收17.380	日振幅5.18%
总市值146.49亿	流通市值146.49亿	总股本8.37亿
成交额3,194万	换手率0.22%	流通股本8.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08138","market":"HK","secType":"STK","nameCN":"同仁堂国药","latestPrice":17.5,"timestamp":1527494918001,"preClose":17.38,"halted":0,"volume":1835659,"delay":0,"floatShares":837100000,"shares":837100000,"eps":0.5853,"marketStatus":"午间休市","marketStatusCode":3,"change":0.12,"latestTime":"05-28 16:08:38","open":17.5,"high":17.84,"low":16.94,"amount":31939333,"amplitude":0.051784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732683600000},"adr":0,"adjPreClose":17.38,"openAndCloseTimeList":[[1732671000000,1732680000000],[1732683600000,1732694400000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08138/tweets","defaultTab":"tweets","newsList":[{"id":"2309332666","title":"大摩：予同仁堂国药(03613)“增持”评级 目标价14.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2309332666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2309332666?lang=zh_cn&edition=full","pubTime":"2023-02-06 11:00","pubTimestamp":1675652413,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，大摩发布研究报告称，予同仁堂国药(03613)“增持”评级，预测股价在未来30日内有超过80%以上机率会上升，目标价14.2港元。该行指出，内地与香港于今日起正式实施免检疫通关，预计旅游及零售业将全面复苏，带动公司业务回升。报告中称，作为同仁堂集团的分支公司，疫前公司港澳零售收入贡献有20%以上来自内地游客，因此该行继续将同仁堂国药视为通关受惠股份，在业务复苏前景及公司2023年双位数的盈利增长指引下，认为目前是不错的入市时机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/871650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03613","08138"],"gpt_icon":0},{"id":"2309645334","title":"《大行报告》大摩相信同仁堂国药(03613.HK)股价30日内将升","url":"https://stock-news.laohu8.com/highlight/detail?id=2309645334","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2309645334?lang=zh_cn&edition=full","pubTime":"2023-02-06 10:03","pubTimestamp":1675648980,"startTime":"0","endTime":"0","summary":"摩根士丹利发表报告，预测同仁堂国药(03613.HK) 的股价在未来30日内有超过80%以上机率会上升。该行指出，内地与本港于今日(6日)起正式实施免检疫通关，预计旅游及零售业将全面复苏，带动同仁堂国药业务回升。作为同仁堂集团的海外分支公司，疫情前公司港澳零售收入贡献有20%以上来自内地游客，因此大摩继续将同仁堂国药视为通关受惠股份，在业务复苏前景及公司2023年双位数的盈利增长指引下，认为现时是不错的入市时机，给予同仁堂国药目标价14.2元，评级“增持”。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2023-02-03 16:25。)","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20181016133726648_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20181016133726648_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1243003/latest-news/HK6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0106831901.USD","IE00BZ1G4Q59.USD","LU1668664300.SGD","BK4581","MS","BK4504","03613","BK1606","BK4534","08138","BK4127","LU0971096721.USD","LU1989772840.SGD","BK4585","LU1074936037.SGD","IE00BKVL7J92.USD","LU1363072403.SGD","BK1191","LU1989772923.USD"],"gpt_icon":0},{"id":"2294607890","title":"同仁堂国药(03613.HK)午后涨近5%，截至发稿，涨4.02%，报11.38港元，成交额1202.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2294607890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294607890?lang=zh_cn&edition=full","pubTime":"2022-12-28 15:33","pubTimestamp":1672212797,"startTime":"0","endTime":"0","summary":"截至2022年12月23日收盘，同仁堂国药报收于10.94元，上涨1.48%，换手率0.11%，成交量89.0万股，成交额980.29万元。投行对该股关注度不高，90天内无投行对其给出评级。同仁堂国药港股市值91.58亿港元，在中药Ⅱ行业中排名第2。主要指标见下表：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2022122800004193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08138","BK1191","BK1606","03613"],"gpt_icon":0},{"id":"2294602822","title":"港股异动 | 同仁堂国药(03613)午后涨近5% 大摩称短期估值吸引 赴港签证恢复将推动业务复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2294602822","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294602822?lang=zh_cn&edition=full","pubTime":"2022-12-28 15:14","pubTimestamp":1672211642,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同仁堂国药(03613)午后涨近5%，截至发稿，涨4.02%，报11.38港元，成交额1202.99万港元。大摩发布研究报告称，近期同仁堂国药股价下跌后令短期估值变得吸引，预计随着1月8日起内地全面放宽出入境管理，将推动公司业务复苏。作为北京同仁堂集团的海外分支，同仁堂国药在疫前港澳零售收入中至少有20%来自内地游客。考虑到复苏前景和明年双位数的盈利增长指引，该行认为14倍的远期市盈率是不错的入市良机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/853442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03613","LU0971096721.USD","BK1191","MS","BK4504","LU1989772923.USD","BK4127","08138","BK4581","LU1989772840.SGD","BK4585","BK4534","LU1363072403.SGD","LU0106831901.USD","BK1606","LU1668664300.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2294608716","title":"大摩：予同仁堂国药增持评级 目标价14.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2294608716","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294608716?lang=zh_cn&edition=full","pubTime":"2022-12-28 11:07","pubTimestamp":1672196877,"startTime":"0","endTime":"0","summary":"大摩发布研究报告称，予同仁堂国药（03613）“增持”评级，相信股价未来30天上升，发生机率在80%以上，目标价14.2港元。\n　　报告指，近期同仁堂国药股价下跌后令短期估值变得吸引，后续公司业务有望复苏。作为北京同仁堂集团的海外分支，在疫前港澳零售收入中至少有20%来自内地游客。考虑到复苏前景和明年双位数的盈利增长指引，该行认为14倍的远期市盈率是不错的入市良机。\n\n炒股开户享福利，入金抽188元红包，100%中奖！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2022-12-28/doc-imxyexph6940318.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2022-12-28/doc-imxyexph6940318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["03613","08138"],"gpt_icon":0},{"id":"2294608583","title":"大摩：予同仁堂国药(03613)“增持”评级 目标价14.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2294608583","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294608583?lang=zh_cn&edition=full","pubTime":"2022-12-28 10:46","pubTimestamp":1672195617,"startTime":"0","endTime":"0","summary":"大摩相信，同仁堂国药(03613)股价未来30天有80%以上机率上升。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20221228/20221228104730_86086.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20221228/20221228104730_86086.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/853346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03613","08138"],"gpt_icon":0},{"id":"2294670861","title":"*大摩相信同仁堂国药(03613.HK)股价未来30天上升  评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2294670861","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2294670861?lang=zh_cn&edition=full","pubTime":"2022-12-28 10:10","pubTimestamp":1672193400,"startTime":"0","endTime":"0","summary":"(港股报价延迟最少十五分钟。沽空资料截至 2022-12-23 16:25。)","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220803121144268_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220803121144268_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1235259/latest-news/HK6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["08138","03613"],"gpt_icon":0},{"id":"2288628936","title":"港股异动 | 中医药概念股午后涨幅扩大 白云山(00874)涨超12% 同仁堂国药(03613)涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2288628936","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2288628936?lang=zh_cn&edition=full","pubTime":"2022-12-01 14:00","pubTimestamp":1669874407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港A两市中医药概念股午后涨幅扩大，A股香雪制药一度涨超15%。截至发稿，白云山涨12.23%，报23.4港元；同仁堂国药涨5.56%，报10.64港元；固生堂涨4.97%，报44.35港元；同仁堂科技涨3.49%，报5.34港元。近期以来，该类药品销量显著增长。据悉，未来，白云山和黄中药公司及广州八院将积极推动透解祛瘟颗粒拓展至其他定点医院和方舱医院使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/840433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK1515","BK0188","BK0183","BK1197","BK0239","03613","01666","BK0096","BK0028","02273","BK1606","BK0196","08138","BK0012","BK0097","600332","BK0175","00874","BK1219","BK1583","BK1191","BK1521"],"gpt_icon":0},{"id":"2274535372","title":"部分中医药概念股走高 同仁堂国药(03613)涨2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2274535372","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2274535372?lang=zh_cn&edition=full","pubTime":"2022-10-10 11:46","pubTimestamp":1665373607,"startTime":"0","endTime":"0","summary":"部分中医药概念股走高，同仁堂国药(03613)涨2.44%，固生堂(02273)涨2.40%，中国中药(00570)涨1.85%，白云山(00874)涨1.55%。消息面上，近日从中药制药共性技术国家重点实验室得到消息：由该实验室为主体研制的国内首条中药口服液条包生产线已建成投产。该项目最大的特点是以新型“塑料袋”代替了传统玻璃瓶用来盛装口服溶液。由此，该生产线每年可处理中药材2.5万吨，年产口服液30亿条包。对中药行业来说，此举尚属首次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=7ec15cea06b80523e904145f21c4f6e0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","08138","BK1191","03613"],"gpt_icon":0},{"id":"2269432290","title":"港股异动 | 同仁堂国药涨4% 下月拟派发特别股息每股0.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2269432290","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269432290?lang=zh_cn&edition=full","pubTime":"2022-09-23 15:31","pubTimestamp":1663918296,"startTime":"0","endTime":"0","summary":"格隆汇9月23日丨同仁堂国药盘中涨4.3%，报9.45港元，总市值79亿港元。同仁堂国药22日发布公告，该公司董事会已决议宣派及派付每股0.25港元的特别股息，总金额为2.09亿港元。预期特别股息将于2022年10月21日(星期五)或前后支付予于2022年10月12日(星期三)名列公司股东名册的股东。同日，同仁堂国药公告，于2022年9月22日，公司与同仁堂股份订立销售框架协议。同仁堂股份集团的成员公司将向集团采购中药产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7702001s2pw.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7702001s2pw.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["BK1191","08138","03613","BK1606"],"gpt_icon":0},{"id":"2269489406","title":"同仁堂国药(03613.HK)午后涨近4%，截至发稿，涨3.86%，报9.41港元，成交额879.6万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2269489406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269489406?lang=zh_cn&edition=full","pubTime":"2022-09-23 14:40","pubTimestamp":1663915223,"startTime":"0","endTime":"0","summary":"截至2022年9月22日收盘，同仁堂国药报收于9.06元，下跌3.21%，换手率0.13%，成交量112.5万股，成交额1023.13万元。投行对该股的评级以买入为主，近90天内共有3家投行给出买入评级，近90天的目标均价为12.95。第一上海最新一份研报给予同仁堂国药买入评级，目标价13.4。机构评级详情见下表：同仁堂国药港股市值75.84亿港元，在中药Ⅱ行业中排名第2。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2022092300004261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","08138","03613","BK1606"],"gpt_icon":0},{"id":"2269353514","title":"港股异动 | 同仁堂国药(03613)午后涨近4% 与控股股东同仁堂股份订立中药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2269353514","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269353514?lang=zh_cn&edition=full","pubTime":"2022-09-23 14:26","pubTimestamp":1663914392,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同仁堂国药(03613)午后涨近4%，截至发稿，涨3.86%，报9.41港元，成交额879.6万港元。　　消息面上，同仁堂国药发布公告，于2022年9月22日，公司与同仁堂股份(公司控股股东)订立销售框架协议。同仁堂股份集团的成员公司将向集团采购中药产品。销售框架协议的期限为由2022年9月22日至2022年12月31日。期间，销售框架协议项下拟进行的交易的建议年度上限为7400万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2022/09/23142637016900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","08138","BK0183","BK1191","BK0239","BK0086","BK0113","BK0196","BK0188","BK0012","03613","BK0097","BK1606","600085"],"gpt_icon":0},{"id":"2269110200","title":"【港股通】同仁堂国药(03613)涨2.21% 与控股股东订立中药产品销售框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2269110200","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269110200?lang=zh_cn&edition=full","pubTime":"2022-09-23 10:49","pubTimestamp":1663901358,"startTime":"0","endTime":"0","summary":"同仁堂国药(03613)早盘震荡走上，最新报9.26港元，涨2.21%，成交额387.56万港元。同仁堂国药公布，于2022年9月22日，公司与同仁堂股份(公司控股股东)订立销售框架协议。同仁堂股份集团的成员公司将向集团采购中药产品。销售框架协议的期限为由2022年9月22日至2022年12月31日。于2022年9月22日至2022年12月31日止期间，销售框架协议项下拟进行的交易的建议年度上限为7400万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=dbe2388d24c96231b22d05fd0eb99440","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","08138","BK1191","03613"],"gpt_icon":0},{"id":"2269774149","title":"同仁堂国药与同仁堂股份订立中药产品销售框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2269774149","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269774149?lang=zh_cn&edition=full","pubTime":"2022-09-22 17:33","pubTimestamp":1663839198,"startTime":"0","endTime":"0","summary":"同仁堂国药（03613）发布公告，于2022年9月22日，公司与同仁堂股份（公司控股股东）订立销售框架协议。同仁堂股份集团的成员公司将向集团采购中药产品。销售框架协议的期限为由2022年9月22日至2022年12月31日。\n　　于2022年9月22日至2022年12月31日止期间，销售框架协议项下拟进行的交易的建议年度上限为7400万港元。\n\n炒股开户享福利，入金抽188元红包，100%中奖！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2022-09-22/doc-imqmmtha8341513.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2022-09-22/doc-imqmmtha8341513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["03613","08138","BK1191","BK1606"],"gpt_icon":0},{"id":"2269149409","title":"同仁堂国药(03613.HK)发布公告，于2022年9月22日，公司与同仁堂股份(公司控股股东)订立销售框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2269149409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269149409?lang=zh_cn&edition=full","pubTime":"2022-09-22 17:20","pubTimestamp":1663838444,"startTime":"0","endTime":"0","summary":"同仁堂股份集团的成员公司将向集团采购中药产品。销售框架协议的期限为由2022年9月22日至2022年12月31日。截至2022年9月22日收盘，同仁堂国药报收于9.06元，下跌3.21%，换手率0.13%，成交量112.5万股，成交额1023.13万元。投行对该股的评级以买入为主，近90天内共有3家投行给出买入评级，近90天的目标均价为12.95。第一上海最新一份研报给予同仁堂国药买入评级，目标价13.4。机构评级详情见下表：同仁堂国药港股市值78.35亿港元，在中药Ⅱ行业中排名第2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2022092200006143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0012","BK0188","BK1191","BK0097","BK0183","BK1606","03613","600085","BK0028","BK0113","BK0196","BK0239","08138"],"gpt_icon":0},{"id":"2269498331","title":"同仁堂国药(03613)与同仁堂股份订立中药产品销售框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2269498331","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269498331?lang=zh_cn&edition=full","pubTime":"2022-09-22 17:11","pubTimestamp":1663837874,"startTime":"0","endTime":"0","summary":"同仁堂国药(03613)发布公告，于2022年9月22日，公司与同仁堂股份(公司控...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/795919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","BK0239","08138","BK0012","03613","BK0188","BK1606","BK0097","BK0086","BK1191","BK0113","BK0183","600085","BK0196"],"gpt_icon":0},{"id":"2269208161","title":"同仁堂国药(03613.HK)订立有关买卖中药产品的销售框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2269208161","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269208161?lang=zh_cn&edition=full","pubTime":"2022-09-22 17:10","pubTimestamp":1663837850,"startTime":"0","endTime":"0","summary":"格隆汇9月22日丨同仁堂国药(03613.HK)发布公告，2022年9月22日，公司与同仁堂股份(公司控股股东)订立销售框架协议。根据销售框架协议，同仁堂股份集团的成员公司将向集团采购中药产品。销售框架协议的期限为由2022年9月22日至2022年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7702001s1q2.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7702001s1q2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["03613","BK1191","BK1606","08138"],"gpt_icon":0},{"id":"2269467431","title":"同仁堂国药(03613.HK)发布公告，该公司董事会已决议宣派及派付每股0.25港元的特别股息，总金额为2.09亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2269467431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269467431?lang=zh_cn&edition=full","pubTime":"2022-09-22 17:00","pubTimestamp":1663837259,"startTime":"0","endTime":"0","summary":"预期特别股息将于2022年10月21日(星期五)或前后支付予于2022年10月12日(星期三)名列公司股东名册的股东。截至2022年9月22日收盘，同仁堂国药报收于9.06元，下跌3.21%，换手率0.13%，成交量112.5万股，成交额1023.13万元。投行对该股的评级以买入为主，近90天内共有3家投行给出买入评级，近90天的目标均价为12.95。第一上海最新一份研报给予同仁堂国药买入评级，目标价13.4。机构评级详情见下表：同仁堂国药港股市值78.35亿港元，在中药Ⅱ行业中排名第2。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2022092200005838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03613","BK1191","BK1606","08138"],"gpt_icon":0},{"id":"2269146417","title":"同仁堂国药将于10月21日派发特别股息每股0.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2269146417","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269146417?lang=zh_cn&edition=full","pubTime":"2022-09-22 16:56","pubTimestamp":1663836960,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　同仁堂国药（03613）发布公告，该公司董事会已决议宣派及派付每股0.25港元的特别股息，总金额为2.09亿港元。预期特别股息将于2022年10月21日（星期五）或前后支付予于2022年10月12日（星期三）名列公司股东名册的股东。\n\n炒股开户享福利，入金抽188元红包，100%中奖！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2022-09-22/doc-imqqsmrp0088666.shtml?finpagefr=p_115","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","03613","BK1606","08138"],"gpt_icon":0},{"id":"2269146696","title":"同仁堂国药(03613)将于10月21日派发特别股息每股0.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2269146696","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2269146696?lang=zh_cn&edition=full","pubTime":"2022-09-22 16:55","pubTimestamp":1663836901,"startTime":"0","endTime":"0","summary":"同仁堂国药(03613)发布公告，该公司董事会已决议宣派及派付每股0.25港元的特...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_6.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_6.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/795890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03613","BK1606","BK1191","08138"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tongrentangcm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.0695},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.051},{"period":"1year","weight":0.0932},{"period":"ytd","weight":0.1239}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"本集团乃於非中国市场以「同仁堂」品牌从事中药产品零售及批发业务的分销商。本集团视自身为於非中国市场推广中医药文化及服务的渠道。本集团乃同仁堂集团的主要海外分销平台。","exchange":"SEHK","name":"同仁堂国药","nameEN":"Beijing Tong Ren Tang Chinese Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同仁堂国药(08138)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同仁堂国药(08138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同仁堂国药,08138,同仁堂国药股票,同仁堂国药股票老虎,同仁堂国药股票老虎国际,同仁堂国药行情,同仁堂国药股票行情,同仁堂国药股价,同仁堂国药股市,同仁堂国药股票价格,同仁堂国药股票交易,同仁堂国药股票购买,同仁堂国药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同仁堂国药(08138)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同仁堂国药(08138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}